Therefore, we further investigate and demonstrate the detailed mechanism in this study by comparing the tumor-intrinsic IFNs and CXCL10 levels in the immunotherapy-sensitive CT26 and immunotherapy-resistant LL/2. The gene discussed is CXCL10; the disease is neoplasm.